He, L. (2023) “SGLT2 Inhibitor And GLP-1 Receptor Agonist in Type 2 Diabetes Mellitus Patients. Research on Their Cardiovascular Benefits”, Highlights in Science, Engineering and Technology, 74, pp. 1717–1722. doi:10.54097/m9vm2798.